US EditionTrump announces reforms to accelerate access to psychedelic drug treatments
The order directs agencies to speed reviews and adds $50 million for state research, while leaving the drugs classified as Schedule I.
- On Saturday, President Donald Trump signed an executive order in the Oval Office to expedite research into psychedelic drugs, including ibogaine, for treating serious mental health conditions.
- Citing data that over 14 million Americans suffer from serious mental illness, HHS Secretary Robert F. Kennedy Jr. and podcaster Joe Rogan urged the president to pursue these therapies.
- Officials committed $50 million to research while directing the Food and Drug Administration to accelerate review timelines via priority vouchers and extend 'Right to Try' provisions for eligible patients.
- Despite the order, ibogaine remains classified as Schedule I, meaning it is illegal outside clinical settings; experts warn of potential cardiovascular risks requiring rigorous clinical validation.
- Proponents believe these therapies could offer veterans life-changing relief where traditional medications have failed, potentially reducing the over 6,000 annual veteran suicides that exceed combat deaths since 9/11.
335 Articles
335 Articles
Executive order on psychedelic-assisted therapies expands on work spearheaded in Texas
HARLINGEN, Texas (ValleyCentral) — After serving as a US Navy SEAL for 13 years, Marcus Capone came home feeling like a different person - and anti-depressants and talk therapy didn't help. “It kind of came to a point where you know, I didn’t want to be here anymore," he said. "I was deeply depressed, there was [...]
The Toronto Star
Waterloo ChronicleHelus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions
NEW YORK and TORONTO, April 20, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP), a clinical stage pharmaceutical company committed to helping minds heal by developing novel
‘Do you want FDA approval?’: Trump wins over Joe Rogan by green-lighting a drug research idea he had from a podcast
Donald Trump signed an executive order on Saturday to accelerate research for specific psychedelic drugs, a move aimed at helping veterans who are struggling with mental health disorders like anxiety and depression. The signing took place in the Oval Office, where podcaster Joe Rogan joined the president after his direct involvement in making this bill happen. .@joerogan says he sent @POTUS information on the extraordinary effects of ibogaine o…
Sunday Links: Trump Signs Order to Fast-Track Psychedelic Research for PTSD, Addiction
Apple Studios is being investigated by UK officials over the 2024 death of a British paraplegic athlete who crashed a plane in the Jordan desert during the filming of Apple’s immersive Vision Pro series, Adventure. Staff had raised safety concerns with superiors prior to the crash that the athletes and production crewmembers were required to work dangerously long hours in harsh climates while operating equipment with limited training. [Bloomberg…
Trump signs order to hasten psychedelic medicine access Phil.Taylor Sun, 19/04/2026
Coverage Details
Bias Distribution
- 59% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
